Company Analysis January 12, 2025 • 12 min read

Carbios (ALCRB.PA)

Enzymatic Plastic Recycling & Sustainable Biochemistry

Community Sentiment Analysis

Sentiment Trends

Loading sentiment trend data...

Recent Community Feedback

Share Your Analysis

Loading engagement options...

Gemini Sentiment Analysis

AI-powered sentiment analysis of market perception based on recent news, analyst reports, and social mentions.

Current Sentiment (1-10): 5.0
Sentiment Trend (Past 10 Days)

Key Takeaways

  • Carbios has developed proprietary enzymatic recycling technology for PET and biodegradation for PLA.
  • First-of-its-kind industrial demonstration plant operational since 2021; commercial plant construction expected to start in 2023.
  • Strategic partnerships with major industry players including L'Oréal, Nestlé Waters, PepsiCo, and Suntory.
  • Solving critical environmental problem with circular economy solution for plastics recycling.
  • Strong IP position with 39 patent families covering enzymatic technologies.

Business Overview

Carbios, founded in 2011, is a leader in developing biological solutions to recycle plastics and textiles. The company's innovative enzyme-based recycling technology breaks down PET plastic and PLA, making it possible to produce high-quality recycled PET (r-PET) and fully biodegradable PLA.

With a strong team of 130 employees—two-thirds in R&D—Carbios holds an impressive intellectual property portfolio of 375 patents across 52 families. Its demonstration plant in Clermont-Ferrand recycles 2 tons of waste, and the upcoming Longlaville plant will increase capacity to 50,000 tons annually.

The company's growth strategy revolves around three key pillars:

Licensing

Granting licenses for its technology and intellectual property to partners.

Enzyme Sales

Selling proprietary enzymes to manufacturers directly or via joint ventures.

Royalties

Earning royalties from partners' sales of recycled PET (r-PET) products.

Technology & Innovation

Carbios has developed functional enzymes able to depolymerize PET and PLA. Monomers of each component are high-quality virgin monomers meaning they can be reused as polymers (R-PET) or remain biodegradable. For PET, the process includes: collection/pre-treatment, depolymerization, filtration, separation of MEG and TA monomers, and final purification. The process is functional at the industrial-demonstration level, with commercial-scale implementation upcoming.

With Carbios ACTIVE, the encapsulated enzyme is added during PLA fabrication with no change to the production line. The additive doesn't affect mechanical properties and is FDA-approved for food contact (EU approval pending). Under composting conditions (temperature, humidity, pH...), the enzyme is activated and the PLA plastic biodegrades completely. This works for both industrial and home compost settings.

Pipeline & Product Roadmap

Carbios' innovation pipeline focuses on enzymatic recycling solutions for plastics and biodegradable polymers. The company is progressing towards full-scale commercialization while expanding its research into new applications.

Today

Industrial demonstration of PET depolymerization and production of high-quality r-PET, showcasing Carbios' readiness for large-scale deployment.

Short Term

Expansion of Carbios ACTIVE for PLA biodegradation, enabling food-safe, fully biodegradable solutions, with active U.S. market rollout and anticipated EU regulatory approvals.

Mid Term

Advanced research into enzymes for other polymer types, such as polyamides and polyolefins, targeting broader sustainability goals and market diversification.

Partnerships & Commercialization

Carbios' ownership structure reflects a blend of strategic partnerships and strong insider participation, ensuring aligned interests with shareholders.

Strategic investors such as L'Oréal (via BOLD), L'Occitane, and Michelin Ventures play a critical role in supporting Carbios' long-term vision.

Major Institutional Investors

  • BOLD (L'Oréal)
  • L'Occitane
  • Michelin Ventures
  • Swedbank Robur
  • Fidelity

Despite recent executive changes and project delays, analysts maintain a positive long-term outlook for Carbios, with many reiterating a "Moderate Buy" rating based on potential upside.

Market Analysis

Carbios' enzymatic process differentiates it from traditional chemical recycling competitors, its market adoption will require scaling operations efficiently and mitigating potential cost barriers. Partnerships with industrial leaders such as Indorama Ventures and consumer brands like L'Oréal have fortified its market presence. However, the emergence of competing technologies from companies like Samsara Eco and Loop Industries necessitates continued innovation to maintain technological leadership.

Financial Analysis

H1 2024 Highlights

Market Cap

€117.08M

Reflects investor anticipation for enzymatic recycling

TTM Revenue

~€83.3K

As of June 30, 2024

Cash & Equivalents

~€144M

Includes term deposits (June 30, 2024)

Total Funding to Date

€314M

Raised since inception

Despite limited current revenues (~€83.3K TTM), Carbios has built a substantial financial runway of ~€144M in cash and deposits as of mid-2024. This capital—bolstered by a €141M capital raise in 2023 and additional public funding—supports ongoing R&D and the construction of the Longlaville industrial facility. While the path to significant revenue hinges on commercializing enzymatic recycling at scale, the company's collaborations, licensing opportunities, and strong IP portfolio position it well for long-term growth in the global push for circular economy solutions.

Intellectual Property

Carbios has a strong IP position with 39 patent families covering enzymatic technologies.

SWOT Analysis

Strengths

  • Unique enzymatic recycling technology for PET and PLA.
  • Significant IP portfolio (375 patent applications).
  • Strong R&D foundation.
  • High-profile collaborations.

Weaknesses

  • Limited revenue streams pre-commercialization.
  • Capital-intensive projects.
  • Dependent on external funding.
  • Still establishing brand awareness.

Opportunities

  • Global demand for circular economy solutions.
  • Expansion potential into other polymer classes.
  • Regulatory drivers creating tailwinds.
  • Possible new partnerships and licensing agreements.

Threats

  • Competition from other recycling methods.
  • Macroeconomic uncertainties.
  • Unforeseen regulatory or environmental hurdles.
  • Operational risks in scaling up production.

Competitive Landscape

Compared to chemical recycling methods, Carbios' enzymatic approach is more energy-efficient and environmentally friendly, offering a competitive edge in markets increasingly shaped by stringent environmental regulations. In comparison to peers like Loop Industries and Quantafuel, Carbios' technology benefits from a cleaner, lower-energy process and a robust set of industrial collaborations. Additionally, its focus on biodegradation technologies for PLA positions the company as a key player in the global shift toward sustainable packaging solutions.

Investment Thesis

Carbios offers a compelling investment opportunity for stakeholders focused on industrial biotech and ESG-aligned growth. Its transition from R&D to commercialization, underscored by key milestones such as the upcoming Longlaville commercial plant, marks a significant inflection point. The anticipated surge in licensing revenue and royalties further supports long-term growth projections. While risks related to market adoption, regulatory approvals, and executive leadership changes remain, the company's strong IP portfolio and strategic partnerships provide a solid foundation for scaling and market penetration.

Conclusion

Carbios is well-positioned to capitalize on the increasing demand for sustainable recycling technologies. The successful operationalization of its Longlaville plant and the expansion of its licensing agreements could significantly enhance its financial profile and global market share. For investors seeking exposure to innovative, sustainability-driven solutions, Carbios represents a strategically sound addition to a diversified portfolio.